Stockscreener 앱 받기
118.55
0.56%
-0.61
전일 마감가:
$119.16
열려 있는:
$119.04
하루 거래량:
552.80K
Relative Volume:
0.62
시가총액:
$14.40B
수익:
$2.72B
순이익/손실:
$254.30M
주가수익비율:
57.37
EPS:
2.0665
순현금흐름:
$564.37M
1주 성능:
-6.05%
1개월 성능:
+1.62%
6개월 성능:
+2.47%
1년 성능:
+15.15%
1일 변동 폭
$116.63
$119.72
1주일 범위
$116.63
$126.57
52주 변동 폭
$97.31
$129.50
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
RVTY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
118.50 | 14.40B | 2.72B | 254.30M | 564.37M | 2.0665 |
|
TMO
Thermo Fisher Scientific Inc
|
571.25 | 218.67B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
206.20 | 148.44B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
145.45 | 41.57B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
458.24 | 37.56B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
207.62 | 36.56B | 15.32B | 1.41B | 1.96B | 7.62 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-08 | 개시 | Leerink Partners | Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
KeyCorp Forecasts Strong Price Appreciation for Revvity (NYSE:RVTY) Stock - MarketBeat
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Trust Point Inc. Purchases Shares of 4,594 Revvity, Inc. (NYSE:RVTY) - MarketBeat
Barclays Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Revvity (NYSE:RVTY) Updates FY 2025 Earnings Guidance - MarketBeat
Jefferies raises Revvity stock price target to $130, maintains Hold - MSN
Revvity anticipates 3%-5% organic growth in 2025 amid market stabilization - MSN
Revvity, Inc. (NYSE:RVTY) Insider Joel S. Goldberg Sells 15,170 Shares - MarketBeat
Revvity’s Strong Recurring Revenue and Growth Prospects Justify Buy Rating - TipRanks
Exchange Traded Concepts LLC Sells 3,502 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Raymond James Adjusts Price Target on Revvity to $145 From $140 -February 03, 2025 at 11:43 am EST - Marketscreener.com
KeyBanc Adjusts Revvity Price Target to $145 From $132 -February 03, 2025 at 11:26 am EST - Marketscreener.com
Revvity (NYSE:RVTY) Receives "Outperform" Rating from Raymond James - MarketBeat
Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
Revvity, Inc. (NYSE:RVTY) Q4 2024 Earnings Call Transcript - MSN
Revvity shares leap over 5% as Q4 earnings top estimates - MSN
Revvity (RVTY) Surpasses Q4 Earnings Estimates - MSN
Revvity’s Strong Q4 Performance and 2025 Outlook - TipRanks
Revvity (NYSE:RVTY) Releases Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Earnings call transcript: Revvity Q4 2024 shows steady growth amid mixed market reaction - MSN
Jefferies raises Revvity stock price target to $130, maintains Hold By Investing.com - Investing.com Australia
Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance
Revvity Reports Positive 2024 Financial Results - TipRanks
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations By Stock Story - Investing.com Canada
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations - Yahoo Finance
RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust - MSN
Revvity's 2025 Guidance Signals Cautious Optimism Amid Slower-Than-Expected Pharma Spending Recovery - Morningstar
Citigroup Raises Price Target on Revvity to $155 From $145 -January 31, 2025 at 02:24 pm EST - Marketscreener.com
Evercore ISI Adjusts Price Target on Revvity to $138 From $125 -January 31, 2025 at 11:35 am EST - Marketscreener.com
Revvity Predicts Lower 2025 Earnings Despite Strong Fourth Quarter - Finimize
Revvity: Q4 Earnings Snapshot - Houston Chronicle
Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending - MSN
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024 - BioSpace
Revvity Inc (RVTY) Q4 2024 Earnings: EPS of $0.78 Beats Estimates, Revenue Hits $729 Million - GuruFocus.com
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
8.65%
4.09%
자본화:
|
볼륨(24시간):